![]() |
市场调查报告书
商品编码
1968515
兽用输液帮浦市场-全球产业规模、份额、趋势、机会、预测:按类型、最终用户、地区和竞争格局划分,2021-2031年Veterinary Infusion Pumps Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End User, By Region & Competition, 2021-2031F |
||||||
全球兽用输液帮浦市场预计将从 2025 年的 3.1245 亿美元成长到 2031 年的 4.7525 亿美元,复合年增长率为 7.24%。
这些医疗设备对于向动物精准输注液体、药物和营养至关重要,其需求主要受全球宠物数量增长和动物医疗保健支出增加的推动。此外,宠物「人性化」运动也进一步促进了这一成长趋势,饲主希望为宠物提供更优质的医疗服务,同时,需要持续输液治疗的慢性动物疾病发生率也不断上升。根据美国宠物用品协会(APPA)预测,到2024年,美国宠物产业的总支出将达到1,520亿美元,这表明饲主愿意在高品质的照护和先进的输液管理技术方面投入大量资金。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 3.1245亿美元 |
| 市场规模:2031年 | 4.7525亿美元 |
| 复合年增长率:2026-2031年 | 7.24% |
| 成长最快的细分市场 | 注射帮浦 |
| 最大的市场 | 北美洲 |
儘管市场条件有利,但仍面临一个重大障碍:现代静脉输液系统购置和维护成本高。小规模兽医诊所往往难以满足这些资金需求,阻碍了发展中地区和预算有限的诊所采用先进技术。因此,儘管对先进医疗服务的需求不断增长,但小规模医疗机构的资金限制仍然阻碍这些重要医疗设备的广泛应用。
慢性疾病和与老龄化相关的兽医问题的日益增多是推动输液帮浦在动物医学领域广泛应用的主要动力。随着伴侣动物寿命的延长,它们更容易患上肾衰竭、癌症和糖尿病等复杂疾病,这些疾病通常需要精准的液体管理和长期用药。肥胖会进一步加剧这些健康风险,导致手术次数增加和重症监护需求上升,因此,自动化输液系统对于确保病患安全至关重要。根据宠物肥胖预防协会于2025年4月发布的《2024年宠物肥胖与营养意见调查》,35%的犬饲主33%的猫饲主表示他们的宠物超重或肥胖,这表明与体重相关的健康问题与对先进治疗设备的需求之间存在直接联繫。
此外,宠物保险覆盖范围的扩大和医疗费用支出的增长对于让更多人能够负担得起这些先进的治疗至关重要。保险覆盖使得饲主更容易选择一些以前被认为过于昂贵的治疗,例如持续输液疗法和术后护理。这种转变体现在保险业的强劲表现上。北美宠物健康保险协会发布的《2025年产业趋势报告》显示,到2024年底,北美投保宠物总数将达到703万隻。此外,英国保险协会(ABI)发布的《2025年报告》指出,上年度宠物保险赔付总额达到创纪录的12.3亿英镑,这使得兽医医院有足够的财力投资高品质的输液泵,以满足用户对先进医疗标准的需求。
现代兽用输液系统的实施和维护成本高昂,是限制市场成长的主要障碍。虽然先进的输液帮浦能够提供更优的输液管理和更高的病人安全性,但它们需要大量的初始投资,这对于小规模或独立动物医院来说往往难以承受。除了购置成本外,专用耗材、定期校准和技术服务的持续费用也给动物医院的营运预算带来了额外的负担。因此,许多资源有限的机构不得不依赖手动输液技术或过时的设备,这有效地阻碍了先进技术的应用。
近期产业财务数据显示兽医诊所面临财务困境,进一步印证了这种经济压力。根据美国兽医协会(AVMA)统计,2024年每位全职兽医的平均总收入约为554,982美元,经通膨调整后,这一数字较历史基准值下降。实际购买力的下降限制了诊所用于设施改善的可支配资金。因此,当兽医院面临收入成长乏力时,它们被迫推迟或放弃对输液帮浦等昂贵医疗设备的投资,这直接阻碍了全球市场的整体扩张。
无线连接和物联网功能的整合正在改变全球兽用输液帮浦市场,满足了动物医疗保健机构对营运效率的迫切需求。诊所正越来越多地采用智慧输液系统,可自动将治疗数据与电子健康记录同步,最大限度地减少人为错误,使医护人员能够专注于患者照护。这些连网设备支援远端输液监控,简化工作流程,同时确保人手不足的医疗机构的安全。这种向数位化优化的转变得到了产业回馈的支持。根据 Covetrus 于 2024 年 7 月发布的报告《2024 年后兽医医疗产业值得关注的关键趋势》,超过 80% 的兽医专业人士表示,他们正在积极优先考虑优化临床技术以减少行政工作量。
同时,在高级住院治疗费用飙升的背景下,居家兽医输液疗法正呈现显着的扩张趋势。兽医医院正在引入小型携带式输液泵,使饲主主人能够在舒适的家中为宠物进行长期治疗,例如化疗和疼痛管理。这种转变有助于宠物更早出院,并有效弥合了必要医疗通讯协定与经济可行性之间的差距。这一趋势的主要目的是减轻宠物饲主的经济负担。根据Synchrony公司2024年10月发布的《兽医专科护理调查》,72%的宠物饲主表示「非常」或「极其」担心专科兽医护理的经济影响,这表明市场对更经济实惠的门诊治疗方案的需求日益增长。
The Global Veterinary Infusion Pumps Market is projected to expand from USD 312.45 Million in 2025 to USD 475.25 Million by 2031, reflecting a compound annual growth rate of 7.24%. These medical devices are essential for delivering precise volumes of fluids, medications, and nutrients to animals, with demand largely fueled by the growing global pet population and rising spending on animal healthcare. This upward trajectory is further bolstered by the increasing incidence of chronic animal diseases requiring sustained fluid therapy, alongside the trend of pet humanization that drives owners to seek superior medical treatments. According to the American Pet Products Association, total U.S. pet industry expenditures hit $152 billion in 2024, highlighting the substantial financial commitment owners are willing to make for high-standard care and advanced fluid management technologies.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 312.45 MIllion |
| Market Size 2031 | USD 475.25 MIllion |
| CAGR 2026-2031 | 7.24% |
| Fastest Growing Segment | Syringe Infusion Pump |
| Largest Market | North America |
Despite these favorable conditions, the market confronts a notable obstacle regarding the substantial acquisition and maintenance expenses linked to modern infusion systems. Small-scale veterinary clinics frequently encounter difficulties meeting these capital requirements, which restricts the broad adoption of such advanced technology in developing areas or practices operating with limited budgets. Consequently, while the demand for sophisticated care grows, financial constraints within smaller facilities continue to hinder the universal implementation of these critical medical devices.
Market Driver
The escalating incidence of chronic and age-related veterinary conditions serves as a major driver for the broad implementation of infusion pumps within animal healthcare. As companion animals enjoy longer lifespans, they become more prone to complex ailments such as renal failure, cancer, and diabetes, which often require exact fluid regulation and prolonged medication administration. Obesity further aggravates these health dangers, resulting in increased surgical procedures and critical care needs where automated infusion systems are vital for ensuring patient safety. According to the Association for Pet Obesity Prevention's '2024 Pet Obesity & Nutrition Opinion Survey' released in April 2025, 35% of dog owners and 33% of cat owners reported their pets were overweight or obese, creating a direct link between weight-related health issues and the demand for sophisticated therapeutic equipment.
Furthermore, the broadening of pet insurance coverage and healthcare spending is pivotal in rendering these advanced treatments financially feasible for a wider audience. With the security of insurance, pet owners are more likely to pursue expensive interventions, such as continuous infusion therapies and post-operative care, which were previously deemed too costly. This shift is reflected in the insurance sector's strong performance; the North American Pet Health Insurance Association's 'State of the Industry Report 2025' noted that the total number of insured pets in North America hit 7.03 million by the end of 2024. Additionally, the Association of British Insurers reported in 2025 that total pet insurance payouts reached a record £1.23 billion for the preceding year, empowering veterinary facilities to purchase high-quality infusion pumps to satisfy the elevated care standards expected by insured clients.
Market Challenge
The substantial expenses involved in acquiring and maintaining modern veterinary infusion systems represent a significant hurdle to market growth. Although advanced infusion pumps provide superior fluid delivery and enhanced patient safety, they necessitate a considerable initial capital outlay that is often difficult for smaller or independent veterinary clinics to justify. In addition to the purchase price, these devices require ongoing funding for specialized consumables, routine calibration, and technical servicing, further burdening the operational budgets of veterinary practices. As a result, many facilities with limited financial resources are forced to depend on manual fluid administration techniques or outdated equipment, which effectively impedes the widespread integration of advanced technology.
This economic strain is underscored by recent industry financial data illustrating the fiscal difficulties practices face. According to the American Veterinary Medical Association, the average gross revenue per full-time equivalent veterinarian in 2024 was approximately $554,982, a figure indicating a decline when adjusted for inflation compared to previous benchmarks. This reduction in real purchasing power restricts the discretionary funds available for practice enhancements. Consequently, when veterinary clinics encounter stagnating revenue, they are compelled to delay or forego investments in expensive medical devices such as infusion pumps, which directly hampers the overall expansion of the global market.
Market Trends
The incorporation of wireless connectivity and IoT capabilities is transforming the Global Veterinary Infusion Pumps Market by meeting the critical demand for operational efficiency in veterinary practices. Clinics are increasingly implementing smart infusion systems that automatically sync treatment data with electronic medical records, thereby minimizing manual entry errors and allowing staff to focus on patient care. These connected devices enable remote monitoring of fluid delivery, which ensures safety while streamlining workflows in understaffed facilities. This movement toward digital optimization is supported by industry feedback; according to the 'Top Veterinary Industry Trends to Watch in 2024 and Beyond' report by Covetrus in July 2024, over 80% of veterinary professionals stated they are actively prioritizing the optimization of practice technology to reduce administrative workloads.
Concurrently, the growth of home-based veterinary infusion therapy is becoming a significant trend, driven by the escalating costs of advanced inpatient care. Veterinary facilities are utilizing compact, ambulatory infusion pumps that allow pet owners to administer long-term treatments, such as chemotherapy or pain management, within the comfort of their homes. This transition facilitates earlier patient discharge, effectively bridging the gap between required medical protocols and financial feasibility. This trend primarily addresses economic pressures on pet owners; according to the 'Veterinary Specialty Care Study' by Synchrony in October 2024, 72% of pet parents expressed being very or extremely concerned regarding the financial impact of specialty veterinary care, stimulating market demand for more affordable outpatient delivery solutions.
Report Scope
In this report, the Global Veterinary Infusion Pumps Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Infusion Pumps Market.
Global Veterinary Infusion Pumps Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: